ArticleArchives of public health = Archives belges de sante publique2025
Age-specific comorbidity risks in osteoarthritis: implications for healthy aging across diverse populations.
Article in Archives of public health = Archives belges de sante publique, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Global Co-Burden and Risk Factors of Low Back Pain and Osteoarthritis: Analysis of Global Burden of Disease 2021 Data Based on Machine Learning and SHAP.Journal of pain research · 2026Article
- Prognostic significance of the CALLY index for cancer risk and survival: evidence from NHANES 2001-2018.World journal of surgical oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOsteoarthritis (OA), a leading cause of disability worldwide, is increasingly recognized for its systemic impact. Despite its prevalence, the age-dependent effects of OA remain underexplored, particularly regarding its association with comorbidities across the life course.
methodsUsing the UK Biobank (78,825 incident OA cases; 301,071 age-/sex-matched controls; age range: 40-86 years) and the CHARLS cohort (China, 5,735 participants, age range: 45-92 years), we employed Cox models with age as the time scale to estimate hazard ratios (HRs) for OA-associated comorbidities, including bone diseases, metabolic disorders, and mental health conditions, stratified by age at diagnosis. Analyses adjusted for sociodemographic factors and population-attributable fractions (PAFs) were calculated to quantify preventable burdens.
resultsOA was associated with significantly increased risks across multiple comorbidities. All comorbidities exhibited an age-dependent gradient: relative risks were highest in younger individuals and declined with age, while absolute risks increased due to OA's higher prevalence in older populations. For example, HRs for metabolic disorders declined from 2.55 (95% CI: 2.36-2.76) in those aged 40-49 to 1.77 (95% CI: 1.74-1.81) in those aged ≥ 70. Validation in CHARLS confirmed these patterns.
conclusionThe systemic effects of OA vary substantially by age at onset. Younger individuals face elevated proportional risks likely shaped by behavioral, occupational, and structural factors, while older adults bear a larger absolute burden. These findings underscore the need for age-sensitive strategies to reduce long-term health consequences of OA and promote healthy aging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.